VIGNA, Giovanni Battista
 Distribuzione geografica
Continente #
NA - Nord America 6.004
EU - Europa 5.921
AS - Asia 2.798
SA - Sud America 615
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 15.393
Nazione #
US - Stati Uniti d'America 5.864
IT - Italia 4.359
SG - Singapore 1.183
CN - Cina 798
BR - Brasile 522
DE - Germania 338
UA - Ucraina 302
HK - Hong Kong 283
TR - Turchia 249
GB - Regno Unito 194
FR - Francia 140
FI - Finlandia 118
SE - Svezia 102
VN - Vietnam 94
RU - Federazione Russa 77
PL - Polonia 73
MX - Messico 64
NL - Olanda 63
CA - Canada 58
ID - Indonesia 35
JP - Giappone 31
CH - Svizzera 29
AR - Argentina 28
BD - Bangladesh 24
EC - Ecuador 23
ES - Italia 23
BE - Belgio 19
IE - Irlanda 18
IN - India 18
ZA - Sudafrica 17
CO - Colombia 16
IQ - Iraq 16
RO - Romania 12
VE - Venezuela 11
MA - Marocco 10
UZ - Uzbekistan 10
IR - Iran 9
LT - Lituania 9
AT - Austria 8
SA - Arabia Saudita 8
PK - Pakistan 7
CZ - Repubblica Ceca 6
GR - Grecia 6
KE - Kenya 5
PY - Paraguay 5
CL - Cile 4
DZ - Algeria 4
JM - Giamaica 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
PE - Perù 3
PH - Filippine 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
CV - Capo Verde 2
DK - Danimarca 2
KR - Corea 2
LU - Lussemburgo 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
HU - Ungheria 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TZ - Tanzania 1
VA - Santa Sede (Città del Vaticano) 1
Totale 15.393
Città #
Singapore 610
Fairfield 608
Woodbridge 555
Ashburn 523
Houston 372
Jacksonville 344
Milan 328
Ann Arbor 326
Rome 310
Beijing 302
Santa Clara 294
Hong Kong 279
Chandler 273
Seattle 270
Cambridge 216
Wilmington 203
Dallas 180
Izmir 153
Naples 119
Nanjing 97
Los Angeles 83
New York 79
Princeton 79
Bremen 77
Turin 64
Munich 63
Palermo 63
Dearborn 57
Boardman 55
Warsaw 55
Bologna 53
The Dalles 50
Padova 49
Ferrara 46
Catania 45
Messina 45
Mexico City 45
Bari 43
São Paulo 43
Florence 40
Turku 38
San Diego 36
Shanghai 33
Nanchang 31
Ho Chi Minh City 30
London 30
Napoli 30
Shenyang 30
Tokyo 29
Verona 29
Genoa 28
Chicago 22
Hanoi 22
Hebei 22
Jiaxing 22
Jakarta 21
Columbus 20
Nuremberg 20
Toronto 20
Addison 19
Mountain View 19
Redwood City 19
Tianjin 19
Ancona 18
Brooklyn 18
Brussels 18
Changsha 17
Parma 17
Rio de Janeiro 17
Falls Church 16
Montreal 16
Perugia 16
Buffalo 15
Moscow 15
Belo Horizonte 14
Southend 14
Caserta 13
Council Bluffs 13
Denver 13
Taranto 13
Orem 12
San Francisco 12
Venice 12
Atlanta 11
Boston 11
Brasília 11
Cagliari 11
Cesena 11
Hefei 11
Norwalk 11
Phoenix 11
Trieste 11
Zhengzhou 11
Johannesburg 10
Kunming 10
Modena 10
Nocera Inferiore 10
Stockholm 10
Torino 10
Andover 9
Totale 8.563
Nome #
Tessuto adiposo e infiammazione sistemica. 2.666
Sindrome metabolica e infiammazione sistemica 1.590
Sindrome metabolica e steatosi epatica: rapporti, meccanismi e determinanti. 299
Acidi Grassi 244
Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study 235
Combining LDL-C and HDL-C to predict survival in late life: The InChianti study 227
Short term effect of four different macronutrient oral loads on metalbolic profile and flow mediated vasodilatation in healthy young men 213
Bilateral strio-pallido-dentate calcinosis (Fahr's disease): Report of seven cases and revision of literature 212
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 196
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 194
Disordini del metabolismo delle lipoproteine 192
Analbuminaemia: a natural model of metabolic compensatory systems 192
Iperlipoproteinemie e ipolipoproteinemie 192
Cor Pulmonale 191
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes 185
Endothelial function and postprandial lipemia 182
Advanced diagnostic support in lipidology project: Role for phenotypic and functional evaluation of lipoproteins in dyslipidemias 180
Reversible hyperthyroidism and cardiomyopathy caused by consumption of iodocasein 179
Dyslipidemia in peripheral vascular disease 179
Chonobiological analysis of sudden death observed in an emergency department 175
Flow-Mediated dilation, carotid wall thickness and hdl function in subjects with hyperalphalipoproteinemia 175
Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers 174
Dyslipidemias in the older subject: features, significance and treatment dilemmas 169
Consensus Document on substitution therapy with DHEA in the elderly 169
Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study) 168
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia 166
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 161
Simvastatin, transdermal patch and oral estrogen-progestin preparation in hypercholesterolemic postmenopausal women: A randomized, placebo-controlled clinical trial 159
The anti-atherogenic properties of HDL particles 157
Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men 156
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 156
Chronobiological approach to renal colic 155
Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis 154
Pharmacotherapy of dyslipidemias in the adult population 150
Nonalcoholic fatty liver and metabolic syndrome in Italy: Results from a multicentric study of the Italian Arteriosclerosis society 145
Circadian periodicity in suicidal behaviour and in opiate overdose syndrome 145
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 145
Hormonal Replacement Therapy and Lipids: Is Transdermal Norethisterone Acetate Better Than Oral Medroxyprogesterone Acetate? 142
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - A post-hoc analysis of a Phase 3, single-arm, open-label trial 141
Role of antioxidants in atherosclerosis: Epidemiological and clinical update 140
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort 140
Transient massive hyperlipidaemia in a type 2 diabetic subject 139
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: A single-arm, open-label, phase 3 study 139
Adverse haematological effects of ticlopidine. A report of four cases 138
Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia 136
Plasma lipoproteins in soy-treated postmenopausal women: a double-blind,placebo-controlled trial 135
Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD) 135
Lipoproteine e dislipoproteinemie. 133
Lipoproteine 133
Iperchilomicronemia: Patologia negletta dagli internisti? [Hyperchylomicronemia: a neglected disease?] 132
Effects of soy on lipoproteins in postmenopausal women: A double blind, multicentre, placebo-controlled trial 131
Low-dose simvastatin treatment in patients with moderate-grade familial hypercholesterolemia 131
Chronobiology of symptomatic supraventricular paroxysmal tachycardia 130
Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia 126
Hypercholesterolemia and the ageing subject 124
Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease 122
Profilo lipidico plasmatico, marcatori di infiammazione e arteriopatia periferica degli arti inferiori: lo studio InCHIANTI 119
Secondary prevention of myocardial infarction and long-term adherence to statin therapy: data from the Alarm2 investigation 117
Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case-control study 115
null 114
Menopausal status, dyslipidemia and thyroid function: a cross sectional study. 112
Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: The GAUSS-3 randomized clinical trial 110
Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol-3-phosphate dehydrogenase 1 deficiency 107
Raggiungimento del target terapeutico nei soggetti avviati al trattamento con statine in pratica clinica. Risultati dallo studio STAR (Statins Target Assessment in Real practice) 105
The benefit and risk of testosterone replacement therapy in older men: effects on lipid metabolism 103
Iperlipoproteinemie e ipolipoproteinemie 102
LIPOPROTEINA (A) E RISCHIO DI MORTE PER TUTTE LE CAUSE IN SOGGETTI ANZIANI FREE-LIVING: LO STUDIO InCHIANTI FOLLOW-UP 102
Testosterone replacement, cardiovascular system and risk factors in the aging male 99
Oli di pesce 96
null 93
Stato di salute e disabilità: risultati di una esperienza di valutazione geriatrica in una RSA 93
Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree 92
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 90
null 87
Lipid abnormalities in patients with extracoronary arteriosclerosis 84
Association between size of Low-Density Lipoprotein Cholesterol and High-Density Lipoprotein Cholesterol particles and cardiovascular events in type 2 diabetes subjects 79
I trial clinici sull'uso delle statine nella cardiopatia ischemica 70
Risk of hospitalization for upper gastrointestinal tract bleeding 66
Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial. 64
Hypolipidemic drugs in elderly subjects: Indications and limits 63
Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia. 54
null 44
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 38
Totale 15.592
Categoria #
all - tutte 57.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.159
Totale 62.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021905 0 0 0 0 0 142 57 136 66 180 159 165
2021/20221.423 55 98 81 114 93 100 85 142 111 128 108 308
2022/20231.614 171 88 115 115 224 166 153 130 162 60 134 96
2023/20241.456 87 97 95 82 85 149 151 116 95 144 161 194
2024/20252.827 116 116 183 180 365 235 137 180 451 286 358 220
2025/20262.654 506 175 542 598 748 85 0 0 0 0 0 0
Totale 15.592